The Pain-Nociceptive Sensor

MedStorm Innovation faces the challenges of improving pain management by offering a unique Pain-Nociceptive Sensor for accurate assessment of real-time painful- and nociceptive stimuli. The Pain-Nociceptive Sensor measures pure changes in skin sympathetic nerve activity (acetylcholine acting on muscarinic receptors) mirrored by changes in skin conductance. The Pain-Nociceptive Sensor is therefore not influenced by hemodynamic and respiratory instability or medication acting on the hemodynamics like beta-blockers and epinephrines. The technology can be used to tailor the individual need for analgesia / anti-nociceptive drugs, to reduce side effects from these drugs and costs for the hospitals.

MedStorm’s technology is based on 20 years of medical research, and there are more than 80 supportive validation studies and 5 theses. Studies show that the Pain-Nociceptive Sensor index increases during pain and nociceptive stimuli, and assess these stimuli more sensitive and specific than the hemodynamics in the different age groups. Moreover, the Pain-Nociceptive index decreases when analgesia / antinociceptive drugs are given. It is found low variation between and within individuals, when they are asleep or uncounsious without any ongoing stimuli.

The Pain-Nociceptive Sensor connects by Bluetooth, which allows wireless transmission of the indices to patient monitors, software applications or electronic medical records. These setups enable a maximum of flexibility and usability: